PharmaBoardroom

Brian Mi – President, IQVIA Greater China

Brian Mi, president of IQVIA Greater China, shares IQVIA’s leadership position in China in both the commercial and R&D space, building on both…

Sora Lee – Vice President & General Manager Korea,…

Syneos Health, established through a merger in 2017, has held a foothold in Korea through its legacy organisations for over 10 years. Sora Lee,…

Narihiko Yoshii – President, Mitsubishi Tanabe Pharma Korea

Narihiko Yoshii, president of Mitsubishi Tanabe Pharma Korea unveils the value that they are bringing to Korean patients by utilising legislation…

Clinical Trials in Korea: Top Facts

An outline of the geographical distribution of clinical trial sites in South Korea. 184 medical institutions were designated by the Korean government…

Spain’s Clinical Trial Landscape

Within the past decade, Spain has developed into a top player in the European clinical trial network. The pharmaceutical industry has been increasing…

Deborah Chee – President, KoNECT, South Korea

Deborah Chee, President of KoNECT (Korea National Enterprise for Clinical Trials), discusses what it takes to build one of the world’s leading…

Dan Zhang – Executive Chairman, Fountain Medical…

Dr Dan Zhang, CEO of Fountain Medical Development (FMD), details the transformation China’s recent membership at the International Conference on…

Dae Jung Kim – President, Daiichi Sankyo Korea

Dae Jung Kim, president of Daiichi Sankyo Korea provides an insight into the rationale behind the company’s focus on the cardiovascular therapeutic…

PJ Brooks – Program Officer, Division of Clinical Innovation…

PJ Brooks PhD, program director in the Office of Rare Diseases Research at the National Center for Advancing Translational Sciences (NCATS), National…